Intranasal Hydromorphone for the Treatment of Acute Pain in Children: A Pilot Study.
Status:
Completed
Trial end date:
2018-04-01
Target enrollment:
Participant gender:
Summary
Intranasal hydromorphone has been shown to be effective in reducing acute pain in adults. It
has not been previously studied in children, but may be a viable option for effectively and
safely reducing pain in children by administering an analgesic by the intranasal route.
This study will be a prospective, open-label pilot study of intranasal hydromorphone in
children with moderate to severe acute pain presenting to the pediatric emergency department.
The investigators aim to describe the amount of pain reduction associated with intranasal
hydromorphone, and to determine the optimal dose of intranasal hydromorphone associated with
a clinically meaningful improvement in acute pain.